Scope and Importance:
From the beginning of the epidemic, almost 75 million people have been infected with the HIV virus and about 36 million people have died of HIV. Globally, 35.3 million [32.2–38.8 million] people were living with HIV at the end of 2012. An estimated 0.8% of adults aged 15–49 years worldwide are living with HIV, although the burden of the epidemic continues to vary considerably between countries and regions. Sub-Saharan Africa remains most severely affected, with nearly 1 in every 20 adults living with HIV and accounting for 71% of the people living with HIV worldwide.
Since the height of the epidemic in the mid-1980s, the annual number of new HIV infections in the United States has been reduced by more than two-thirds, from roughly 130,000 to 50,000 annually. Atlanta finds itself the number five ranked city when it comes to new diagnoses of HIV — a statistic that is rooted in HIV testing not being offered in places where most people get access to health care. Grady Hospital is the only emergency department in Atlanta that offers an HIV test to every patient regardless of why they are in need of care. Various universities and research institutes like EMORY university, CDC Atlanta etc performs various research based on HIV/AIDS.
Awareness and knowledge on HIV/AIDS, STDs and STIs
Viral, Bacterial, Fungal and Protozoan STDs
Understanding and identifying HIV: HIV Related Infections, Co-Infections and Cancers
Primary HIV Infection Transmission and Eradication Issues
Global Epidemiology of HIV/AIDS, STDs, and STIs
HIV research and therapy
Social Strategies for HIV and STDs Prevention
AIDS stigma and discrimination
Lived experience of HIV
Emerging Technologies towards HIV/AIDS
Why to attend??
STD-AIDS-2015 could be an exceptional event that brings along a novel and International mixture of giant and medium HIV/AIDS analysis, leading universities and HIV/AIDS analysis establishments creating the conference an ideal platform to share expertise, foster collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in HIV fields are hallmarks of this conference.
HIV/AIDS in USA
- USA stands at 8th rank in people living with HIV
- 1.2 million People are living with HIV in the USA.
- 50,000 new HIV infections per year
- 50 states in USA use antiretroviral therapy for decline in AIDS incidence.
- Around 150 HIV clinics in USA. HIV/AIDS in Georgia
- Infection rates are high in Georgia and metro Atlanta
- Georgia ranked 4th in the number of new AIDS cases, 7th in cumulative AIDS cases and 8th in the number of persons living with AIDS in 50 states
- Atlanta show more than 26,000 people living with HIV/AIDS, and more than 9,500 of these (37%) have diagnosed AIDS cases
Fig 1: International Statistics on People living with HIV AIDS 
Noble Prizes on HIV/AIDS
- Howard M. Temin: Reverse transcriptase that translates RNA into DNA: (1975)
- David Baltimore: RNA viruses can transfer their information to DNA (1975)
- Françoise Barré-Sinoussi (2008): HIV structure
- Luc Antoine Montagnier (2008): HIV structure
Great survivors of HIV/AIDS
Australian entertainer; played the role of himself in the musical Frames coming out
American MTV actor, AIDS activist, and pastry chef.
American HIV specialist physician, immunologist, and HIV/AIDS advocate; co-founder of the Robert James Frascino AIDS Foundation.
Strategies: Fig 2: Members Associated to HIV/AIDS
HIV/AIDS Hospitals and clinics in Georgia
- The Grady Health System Infectious Disease Program
- AID Atlanta's Health Services Clinic
Around 70 Clinics in and around Georgia at Orlando, north carolina, Illinious etc which are listed below in a graphical representation:
Fig 3: Review on Hospitals and Medical Centers doing HIV research in USA(74)
Fig 3: Explains the statistics showing New York (7) and Chicago(6) having highest number of HIV/AIDS hospitals and medical centers in USA
Important Associations in USA working on HIV
- Centers for Disease Control and Prevention
- NIH(National institute of allergy and infectious diseases)
- Noida having 40 associations of HIV
Fig 4: Associations on HIV/AIDS in USA 
Companies working on HIV medication
America’s biopharmaceutical research companies are currently developing 44 innovative medicines and vaccines.
- ViiV Healthcare & generic
- Bristol-Myers Squibb & generic
- Gilead Sciences & generic
- Abbott & generic
MARKET ESTIMATES AND FORECASTS, 2010-2016 ($ MILLIONS)
- Global HIV/AIDS market, including branded products and generics, was valued at $11.3 billion in 2010.
- $11.8 billion in 2011 and increase at a 4.6% compound annual growth rate (CAGR) over the 2011-2016 forecast period to reach $14.1 billion in 2016.
- Branded products to treat HIV/AIDS were worth nearly $10.7 billion in 2010 and should reach $11 billion in 2011. This sector is expected to reach $13.2 billion in 2016, a compound annual growth rate (CAGR) of 4.6%.
Fig 5: HIV branded products and generics market value (2010-2016)
Fig 6: Products to treat HIV 2010- 2016 (Global)
Funding allotted on HIV/AIDS
- The Global Fund began with a dream: a dream of creating a “war chest” of funding that would support the fight against AID. Today that dream is a reality. Programs supported by the Global Fund in more than 140 countries, as of mid-2014, have 6.6 million people on antiretroviral therapy for AIDS.
- 12,958 donor-funded projects every year
World Health Organization (WHO) HIV/AIDS treatment guidelines; WHO Prequalification Programme (WHO Prequal) and United States (US) Food and Drug Administration (FDA) approvals; and procurement policies of the Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM), US President's Emergency Plan for AIDS Relief (PEPFAR) and UNITAID.
- stavudine-based regimen ($88/person/year)
- zidovudine- ($154-260/person/year)
- tenofovir-based ($244-465/person/year) regimens.
Fig 7: Global funds allocations for 2014-2016 
Fig 8: Cumulative Signed Funding Table(2002-2013)